Neoplastic cell percentage estimation in tissue samples for molecular oncology: recommendations from a modified Delphi study-Reference-Cited by-同舟云学术

Neoplastic cell percentage estimation in tissue samples for molecular oncology: recommendations from a modified Delphi study

Published:2019-07-18 Issue:3 Volume:75 Page:312-319
ISSN:0309-0167
Container-title:Histopathology
language:en
Short-container-title:Histopathology

Author:

Dufraing Kelly¹²^ORCID,Krieken J Henricus²^ORCID,De Hertogh Gert³^ORCID,Hoefler Gerald⁴^ORCID,Oniscu Anca⁵,Kuhlmann Tine P⁶,Weichert Wilko⁷,Marchiò Caterina⁸⁹,Ristimäki Ari¹⁰,Ryška Aleš¹¹^ORCID,Scoazec Jean‐Yves¹²,Dequeker Elisabeth¹

Affiliation:

1. Biomedical Quality Assurance Research Unit, Department of Public Health and Primary Care KU Leuven Leuven Belgium

2. Department of Pathology Radboud University Medical Center Nijmegen the Netherlands

3. Department of Pathology University Hospital Leuven Leuven Belgium

4. Diagnostic and Research Institute of Pathology Medical University of Graz Graz Austria

5. Department of Molecular Pathology, Laboratory Medicine Royal Infirmary of Edinburgh Edinburgh UK

6. Department of Pathology Herlev Hospital Copenhagen Denmark

7. Department of Pathology Technical University Munich Munich Germany

8. Department of Medical Sciences University of Turin and Pathology Unit TorinoItaly

9. FPO‐IRCCS Candiolo Cancer Institute Candiolo Italy

10. Department of Pathology, Research Programs Unit and HUSLAB University of Helsinki and Helsinki University Hospital Helsinki Finland

11. The Fingerland Department of Pathology Faculty of Medicine and University Hospital Hradec Kralove Czech Republic

12. Pathology Department Gustave Roussy Villejuif France

Publisher

Wiley

Subject

General Medicine,Histology,Pathology and Forensic Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/his.13891

Reference34 articles.

1. Personalized and precision medicine: integrating genomics into treatment decisions in gastrointestinal malignancies

2. Tumor biomarker testing in non-small-cell lung cancer: A decade of change

3. Challenges in molecular testing in non-small-cell lung cancer patients with advanced disease

4. Imprecision in the Era of Precision Medicine in Non-Small Cell Lung Cancer

5. Clinical Validation of KRAS, BRAF, and EGFR Mutation Detection Using Next-Generation Sequencing

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Artificial intelligence algorithm for neoplastic cell percentage estimation and its application to copy number variation in urinary tract cancer;Journal of Pathology and Translational Medicine;2024-08-09

2. Analysis of Factors Determining Success in FFPE Based NGS Panel Testing For Lung & Ovarian Cancer;2024-07-29

3. Pathologist Computer-Aided Diagnostic Scoring of Tumor Cell Fraction: A Swiss National Study;Modern Pathology;2023-12

4. Guidelines for molecular testing in non-small cell lung cancer – recommendations from the Brazilian Society of Pathology;Surgical and Experimental Pathology;2023-10-10

5. Thrombotic Microangiopathy in the Renal Allograft: Results of the TMA Banff Working Group Consensus on Pathologic Diagnostic Criteria;Transplant International;2023-08-23